SG11201704668PA - Treatment of retinal degeneration using progenitor cells - Google Patents
Treatment of retinal degeneration using progenitor cellsInfo
- Publication number
- SG11201704668PA SG11201704668PA SG11201704668PA SG11201704668PA SG11201704668PA SG 11201704668P A SG11201704668P A SG 11201704668PA SG 11201704668P A SG11201704668P A SG 11201704668PA SG 11201704668P A SG11201704668P A SG 11201704668PA SG 11201704668P A SG11201704668P A SG 11201704668PA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- progenitor cells
- retinal degeneration
- retinal
- degeneration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462092658P | 2014-12-16 | 2014-12-16 | |
| US201562236732P | 2015-10-02 | 2015-10-02 | |
| PCT/US2015/063931 WO2016099949A2 (en) | 2014-12-16 | 2015-12-04 | Treatment of retinal degeneration using progenitor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201704668PA true SG11201704668PA (en) | 2017-07-28 |
Family
ID=56110114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201704668PA SG11201704668PA (en) | 2014-12-16 | 2015-12-04 | Treatment of retinal degeneration using progenitor cells |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20160166619A1 (en) |
| EP (1) | EP3233096A4 (en) |
| JP (1) | JP2018500325A (en) |
| KR (1) | KR20170094368A (en) |
| CN (1) | CN107249608A (en) |
| AU (1) | AU2015363088A1 (en) |
| BR (1) | BR112017012581A2 (en) |
| CA (1) | CA2970641A1 (en) |
| MX (1) | MX2017007953A (en) |
| PH (1) | PH12017501028A1 (en) |
| RU (1) | RU2017124983A (en) |
| SG (1) | SG11201704668PA (en) |
| TW (1) | TW201632620A (en) |
| WO (1) | WO2016099949A2 (en) |
| ZA (1) | ZA201704793B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| CN108291199A (en) * | 2015-12-04 | 2018-07-17 | 詹森生物科技公司 | Retinosis is treated using progenitor cells |
| JP6799248B2 (en) * | 2016-09-28 | 2020-12-16 | 澁谷工業株式会社 | How to cut the cell sheet |
| WO2018102174A1 (en) * | 2016-12-01 | 2018-06-07 | Janssen Biotech, Inc. | Treatment of retinal degeneration using progenitor cells |
| KR102091567B1 (en) * | 2018-06-15 | 2020-03-20 | 인하대학교 산학협력단 | Pharmaceutical composition for prevention or treatment of brain injury comprising the osteopontin protein fragment as an active ingredient |
| CN109456937A (en) * | 2018-12-27 | 2019-03-12 | 广州赛莱拉干细胞科技股份有限公司 | A kind of culture medium preparing Endometrial stem cell and preparation method |
| US10881693B2 (en) | 2019-04-09 | 2021-01-05 | Combangio, Inc. | Processes for making and using a mesenchymal stem cell derived secretome |
| CN115998845A (en) * | 2020-10-26 | 2023-04-25 | 上海交通大学医学院附属第九人民医院 | Application of thrombospondin 1 in preparation of medicine for preventing and/or treating retina injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8790637B2 (en) * | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| US9572840B2 (en) * | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
| JP4950659B2 (en) * | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | Most postpartum cells derived from placental tissue and methods of making and using them. |
| US20130251670A1 (en) * | 2011-09-13 | 2013-09-26 | Aidan Products, Inc | Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof |
-
2015
- 2015-12-04 CA CA2970641A patent/CA2970641A1/en not_active Abandoned
- 2015-12-04 AU AU2015363088A patent/AU2015363088A1/en not_active Abandoned
- 2015-12-04 WO PCT/US2015/063931 patent/WO2016099949A2/en active Application Filing
- 2015-12-04 EP EP15870680.4A patent/EP3233096A4/en not_active Withdrawn
- 2015-12-04 US US14/960,006 patent/US20160166619A1/en not_active Abandoned
- 2015-12-04 JP JP2017532063A patent/JP2018500325A/en active Pending
- 2015-12-04 MX MX2017007953A patent/MX2017007953A/en unknown
- 2015-12-04 BR BR112017012581A patent/BR112017012581A2/en not_active Application Discontinuation
- 2015-12-04 CN CN201580076297.2A patent/CN107249608A/en active Pending
- 2015-12-04 SG SG11201704668PA patent/SG11201704668PA/en unknown
- 2015-12-04 KR KR1020177019177A patent/KR20170094368A/en unknown
- 2015-12-04 RU RU2017124983A patent/RU2017124983A/en not_active Application Discontinuation
- 2015-12-16 TW TW104142367A patent/TW201632620A/en unknown
-
2017
- 2017-06-02 PH PH12017501028A patent/PH12017501028A1/en unknown
- 2017-07-14 ZA ZA2017/04793A patent/ZA201704793B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017124983A (en) | 2019-01-17 |
| CA2970641A1 (en) | 2016-06-23 |
| MX2017007953A (en) | 2018-02-09 |
| PH12017501028A1 (en) | 2018-03-05 |
| US20160166619A1 (en) | 2016-06-16 |
| ZA201704793B (en) | 2019-01-30 |
| JP2018500325A (en) | 2018-01-11 |
| CN107249608A (en) | 2017-10-13 |
| KR20170094368A (en) | 2017-08-17 |
| BR112017012581A2 (en) | 2017-12-26 |
| EP3233096A4 (en) | 2018-08-22 |
| RU2017124983A3 (en) | 2019-06-05 |
| AU2015363088A1 (en) | 2017-06-15 |
| WO2016099949A2 (en) | 2016-06-23 |
| EP3233096A2 (en) | 2017-10-25 |
| TW201632620A (en) | 2016-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1245829A1 (en) | Methods for controlled elimination of therapeutic cells | |
| HK1245827B (en) | Methods for controlled activation or elimination of therapeutic cells | |
| HK1244826A1 (en) | Methods and compositions for adoptive cell therapy | |
| HK1246179A1 (en) | Methods of treating retinal diseases | |
| IL251468A0 (en) | Aav-based gene therapy | |
| HRP20181487T1 (en) | Implantable electrode arrangement | |
| GB201701673D0 (en) | Methods of well treatment | |
| ZA201704793B (en) | Treatment of retinal degeneration using progenitor cells | |
| GB201403260D0 (en) | Treatment of retinal degeneration using gene therapy | |
| IL285258A (en) | Retinal ganglion cells and progenitors thereof | |
| IL251013A0 (en) | Implantable electrode | |
| PL3233174T3 (en) | Intraocular delivery of bioactive molecules using iontophoresis | |
| HRP20190334T1 (en) | Implantable electrode arrangement | |
| GB201416832D0 (en) | Methods of treatment | |
| HK1249866A1 (en) | Methods of treatment with taselisib | |
| EP3213762A4 (en) | Novel treatment of cornea using laminin | |
| HK1250329A1 (en) | Treatment of ocular conditions using progenitor cells | |
| ZA201608406B (en) | Enzyme treatment composition | |
| EP3384009A4 (en) | Treatment of retinal degeneration using progenitor cells | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| HK1245069A1 (en) | Improvements relating to retinal treatment | |
| ZA201608404B (en) | Enzyme treatment composition | |
| GB201407806D0 (en) | Treatment of fibrosis | |
| PT3851537T (en) | Treatment of hyperbilirubinemia | |
| AU2014904206A0 (en) | Treatment of fibrosis |